138 related articles for article (PubMed ID: 29970427)
21. Prognostic classification of MDS is improved by the inclusion of FISH panel testing with conventional cytogenetics.
Kokate P; Dalvi R; Koppaka N; Mandava S
Cancer Genet; 2017 Oct; 216-217():120-127. PubMed ID: 29025586
[TBL] [Abstract][Full Text] [Related]
22. Molecular cytogenetics.
Kearney L
Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes.
Flactif M; Lai JL; Preudhomme C; Fenaux P
Leukemia; 1994 Jun; 8(6):1012-8. PubMed ID: 8207974
[TBL] [Abstract][Full Text] [Related]
24. The impact of the new fish technologies on the cytogenetics of haematological malignancies.
Kearney L
Br J Haematol; 1999 Mar; 104(4):648-58. PubMed ID: 10192422
[No Abstract] [Full Text] [Related]
25. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
Jha CB; Kucheria K; Choudhary VP
Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
[TBL] [Abstract][Full Text] [Related]
26. [Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].
Gao DG; Li BT; Zhou LN; Chen H; Zhang B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1190-4. PubMed ID: 24156432
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal heterogeneity of aneuploid leukemic cell populations detected by conventional karyotyping and by fluorescence in situ hybridization (FISH).
Gebhart E; Trautmann U; Reichardt S; Liehr T
Anticancer Res; 1993; 13(5C):1857-62. PubMed ID: 8267393
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia.
Le Gouill S; Talmant P; Milpied N; Daviet A; Ancelot M; Moreau P; Harousseau JL; Bataille R; Avet-Loiseau H
J Clin Oncol; 2000 Apr; 18(7):1533-8. PubMed ID: 10735902
[TBL] [Abstract][Full Text] [Related]
29. Comparison of metaphase and interphase FISH monitoring of minimal residual disease with MLL gene probe: case study of AML with t(9;11).
Gallo JH; Robson LG; Watson NW; Sharma P; Smith A
Ann Genet; 1999; 42(2):109-12. PubMed ID: 10434126
[TBL] [Abstract][Full Text] [Related]
30. Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Gisslinger H; Zojer N; Ludwig H
Cancer; 2006 Dec; 107(12):2801-6. PubMed ID: 17103442
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal cytogenetic study of metaphase and interphase cells in childhood monosomy 7 syndrome.
Stanley WS; Devine GC; Murphy BA; Seibel N; Dinndorf P
Cancer Genet Cytogenet; 1992 Sep; 62(2):160-5. PubMed ID: 1394103
[TBL] [Abstract][Full Text] [Related]
32. The parallel application of karyotype interphase and metaphase FISH after DSP-30/IL-2 stimulation is necessary for the investigation of chronic lymphocytic leukemia.
Karakosta M; Manola KN
Hematology; 2016 Oct; 21(9):526-35. PubMed ID: 27077766
[TBL] [Abstract][Full Text] [Related]
33. [Cytogenetic study of 121 patients suffering from various hematologic neoplasms using the in situ hybridization technique].
Pérez Losada A; Solé F; Woessner S; Florensa L; Besses C; Espinet B; Caballín MR; García Eroles L; Sans-Sabrafén J
Sangre (Barc); 1996 Jun; 41(3):201-9. PubMed ID: 8755208
[TBL] [Abstract][Full Text] [Related]
34. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
35. Determination by interphase-FISH of the clonality of aberrant karyotypes in human hematopoietic neoplasias.
Gebhart E; Liehr T; Harrer P; Reichardt S; Schmitt G; Thoma K; Gramatzki M; Trautmann U
Leuk Lymphoma; 1995 Apr; 17(3-4):295-302. PubMed ID: 8580799
[TBL] [Abstract][Full Text] [Related]
36. An abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era.
Tan D; Teoh G; Lau LC; Lim A; Lim TH; Yap KC; Premalatha P; Lao ZT; Wee N; Choo C; Wee HC; Su S; Lee YS; Lee LH; Hwang W; Goh YT
Am J Hematol; 2010 Oct; 85(10):752-6. PubMed ID: 20721886
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of conventional cytogenetics and interphase fluorescence in situ hybridization in diagnosis of acute promyelocytic leukemia].
Wang R; Miao KR; Qiu HR; Qian SX; Hong M; Qiao C; Zhag JF; Fan L; Wu HX; Lu H; Qiu HX; Chen LJ; Zhag SJ; Xu W; Liu P; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):983-6. PubMed ID: 21867629
[TBL] [Abstract][Full Text] [Related]
38. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
[TBL] [Abstract][Full Text] [Related]
39. [Contribution of phenotyping cells in metaphase and interphase (MAC and MACISH techniques) to the study of hematologic neoplasms].
Pérez-Losada A; Woessner S; Solé F; Florensa L
Med Clin (Barc); 1997 Nov; 109(16):611-4. PubMed ID: 9463133
[TBL] [Abstract][Full Text] [Related]
40. Single-cell trisomy in hematologic malignancy. Random change or tip of the iceberg?
Kasprzyk A; Mehta AB; Secker-Walker LM
Cancer Genet Cytogenet; 1995 Nov; 85(1):37-42. PubMed ID: 8536235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
